在同时服用蒂扎尼丁和利西诺普里尔后,严重的低血压
Kayla Setzer1, Nicholas Baldwin2, Tracey Mersfelder3
1Internal Medicine and Pediatrics, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA kayla.setzer@wmed.edu.
BMJ case reports
|February 12, 2025
概括
一种罕见但严重的tizanidine和lisinopril之间的药物相互作用可以导致严重的低血压. 医疗保健提供者应密切监测患者,当这些药物一起处方时,以防止不良事件.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 提扎尼丁是一种肌肉放松剂,作为中央α-2上腺激动剂的激动剂.
- 众所周知,α-2上腺激动剂会引起胸肌梗塞和低血压.
- 该患者有高血压病史和慢性背痛.
研究的目的:
- 报告一种罕见但严重的tizanidine和lisinopril之间的药物相互作用.
- 为了突出这种组合导致的严重低血压的潜力.
主要方法:
- 一个50多岁的男性患者的病例报告.
- 审查患者的药物 anamnesis,包括tizanidine和lisinopril.
- 观察患者对药物给药和停药的反应.
主要成果:
- 患者经历了与蒂桑尼丁服药相关的低血压发作.
- 当tizanidine与lisinopril结合使用时,低血压变得更加明显.
- 停用蒂扎尼丁可以缓解低血压发作.
结论:
- 提扎尼丁-利西诺普里尔药物相互作用可能导致严重的,可能危及生命的低血压.
- 这种相互作用很少见,但需要临床意识.
- 医疗保健提供者应对这种药物不良反应保持警.
相关概念视频
Antihypertensive Drugs: Thiazide-Class Diuretics
523
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
523
Alterations in Blood Pressure
1.2K
Alterations in blood pressure, such as hypertension (high blood pressure) and hypotension (low blood pressure), significantly affect human health. Understanding these conditions' classifications, causes, and symptoms is essential for effective management and treatment.
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...
1.2K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
460
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
460
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
374
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
374
Antihypertensive Drugs: Potassium-Sparing Diuretics
439
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
439
Antihypertensive Drugs: Angiotensin II Receptor Blockers
573
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
573


